Onconova Therapeutics Inc (NASDAQ: TRAW) stock suffered a major decline of -10.6% on 1/8/25. The shares closed at $8.07. However, this decline was accompanied by exceptionally low trading volume at 11% of normal. The stock has been extremely weak relative to the market over the last nine months and has declined -4.2% during the last week.
Current PriceTarget Research Rating
Onconova Therapeutics has a current Value Trend Rating of F (Lowest Rating). This rating combines highly consistent signals from two proprietary PTR measures of a stock’s attractiveness. Onconova Therapeutics has a very low Power Rating of 4 and a very low Appreciation Score of 0, triggering the Lowest Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment